ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
